구조적 심질환용 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별(SAVR, TAVR, 승모판 수복, LAAC), 지역별, 경쟁별(2020-2030년)

The Global Structural Heart Devices Market, valued at USD 7.20 Billion in 2024, is projected to experience a CAGR of 9.11% to reach USD 12.15 Billion by 2030. Structural heart devices comprise medical implants and systems addressing anatomical defects or disorders of the heart's valves, chambers, or major arteries, typically via minimally invasive procedures. Market growth is fueled by the escalating global prevalence of structural heart diseases, particularly in the aging population. The increasing adoption of minimally invasive interventions, such as Transcatheter Aortic Valve Replacement, offering reduced recovery times and improved patient outcomes, further propels market expansion, alongside ongoing technological advancements.

Key Market Drivers

The rising prevalence of structural heart diseases represents a fundamental driver for the global structural heart devices market, creating a substantial and expanding patient demographic requiring advanced therapeutic interventions. Conditions such as valvular heart disease, cardiomyopathy, and congenital heart defects, which often necessitate mechanical correction or replacement, are increasingly being diagnosed due to improved awareness and diagnostic capabilities. This growing disease burden directly translates into a higher demand for innovative devices like transcatheter heart valves and annuloplasty rings. For instance, according to "The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management", in March 2023, more than 4% of people over 75 years old were found to have a clinically relevant tricuspid regurgitation, highlighting the significant need for effective treatment solutions for various structural heart conditions beyond previously highlighted disorders.

Key Market Challenges

The substantial cost associated with advanced structural heart devices presents a significant impediment to the growth of the Global Structural Heart Devices Market. These high expenses directly impact healthcare budgets and reimbursement policies, particularly in health systems with constrained financial resources. This economic barrier can restrict the widespread adoption of innovative therapies, limiting access for a broader patient population across different economic regions.

Key Market Trends

Advancements in Interventional Imaging and AI-Guided Navigation

This trend underscores the evolving sophistication of imaging modalities and the integration of artificial intelligence in guiding structural heart interventions. These technological enhancements improve procedural precision and safety, ultimately contributing to favorable patient outcomes. AI-driven algorithms assist in real-time visualization, optimal device placement, and comprehensive pre-procedural planning, which can refine procedural pathways. For instance, according to the American College of Cardiology's Annual Scientific Session, in March 2025, patients whose evaluation was non-invasively guided by a novel, AI-powered technique underwent approximately 1% fewer procedures with comparable outcomes to those guided by ultrasound-based imaging.

Key Market Players

• Abbott Laboratories, Inc.
• Edwards Lifesciences Corporation
• Medtronic Plc
• Boston Scientific Corporation
• Lepu Medical Technology Holding Company
• TTK Healthcare Limited
• Biomerics, LLC
• Braile Biomedic
• Artivion, Inc.
• JenaValve Technology Inc

Report Scope:

In this report, the Global Structural Heart Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Structural Heart Devices Market, By Type:

• SAVR (Surgical Aortic Valve Replacement)
• TAVR (Transcatheter Aortic Valve Replacement)
• Mitral Repair (Annuloplasty)
• LAAC (Left Atrial Appendage Closure)

Structural Heart Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Structural Heart Devices Market.

Available Customizations:

Global Structural Heart Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Structural Heart Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure))
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Structural Heart Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Structural Heart Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Canada Structural Heart Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Mexico Structural Heart Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type

7. Europe Structural Heart Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Structural Heart Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. France Structural Heart Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Structural Heart Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Structural Heart Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Structural Heart Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Structural Heart Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Structural Heart Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Structural Heart Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. Japan Structural Heart Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. South Korea Structural Heart Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Structural Heart Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. Middle East & Africa Structural Heart Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Structural Heart Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. UAE Structural Heart Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. South Africa Structural Heart Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. South America Structural Heart Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Structural Heart Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Colombia Structural Heart Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. Argentina Structural Heart Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Structural Heart Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Edwards Lifesciences Corporation
• 15.3. Medtronic Plc
• 15.4. Boston Scientific Corporation
• 15.5. Lepu Medical Technology Holding Company
• 15.6. TTK Healthcare Limited
• 15.7. Biomerics, LLC
• 15.8. Braile Biomedic
• 15.9. Artivion, Inc.
• 15.10. JenaValve Technology Inc

16. Strategic Recommendations

17. About Us & Disclaimer